💡If you're interested in the #AMR results from the COMBACTE projects, join us on 31 May for our Impact webinar - Combatting antimicrobial restistance🦠: the legacy of the COMBACTE projects. More info & register here: europa.eu/!V6mTBY

Today we celebrate #ClinicalTrialsDay recognising groundbreaking innovations, but more importantly the clinical researchers behind them. Their efforts, dedication & curiosity leading to these breakthroughs #CTD2024
Innovative Health Initiative EFPIA Infection & Immunity UMC Utrecht Ecraid ACRP - Assoc. of Clinical Research Profession European Commission

Save the date - 31 May 2024 - to find how the COMBACTE projects leveraged #PPP to combat #AntimicrobialResistance , which causes more than 35K deaths/year. Register now: europa.eu/!V6mTBY #EUResearch #EUInnovation

🦠 The IMI-supported EMBLAVEO®, which received marketing authorisation from the European Commission last week, is desperately needed, says an infectious disease expert involved in the IMI-supported Phase III REVISIT trial.
👀 Read more: europa.eu/!QdG9tT
COMBACTE

At 12:00 today our own Claudia Recanatini is presenting results from COMBACTE-NET’s ASPIRE-ICU at #ESCMIDGlobal2024 in the Poster Area!
Innovative Health Initiative Infection & Immunity UMC Utrecht ESCMID

Ready for the 3rd day at #ESCMIDGlobal2024 ! Today our colleague from Laboratory of Medical Microbiology UA is presenting results from COMBACTE-NET's ASPIRE-ICU observational study. Check it out! Innovative Health Initiative EFPIA ESCMID Ecraid

With less than 3h until Ecraid's Young Investigator Workshop, Ana C Hernandez is putting the final touches on her presentation ⌨️

Don't miss it, on-site or online:

🕢 15:30 - 16:30
📍 Rooms 8.34 + 8.35
🖥 Online 👉🏾 key4events.zoom.us/j/84257814360?…

#ESCMIDGlobal2024 #ECCMID2024 CHU de Limoges

Day 2 at #ESCMIDGlobal2024 and we are ready to tell you more about Ecraid’s sustainable #clinicalresearch networks for #infectiousdiseases that were built in the EU-funded COMBACTE and PREPARE Europe. See you at booth E81! Innovative Health Initiative EFPIA ESCMID European Commission

Come pick up a copy of our COMBACTE magazine at the Ecraid booth E81! Get an overview of COMBACTE’s milestones & achievements in #antimicrobialresistance research and the sustainable clinical networks that now continue in Ecraid Innovative Health Initiative EFPIA EUScience&Innovation🇪🇺 European Commission

Head over to Arena 2 for a presentation on #pneumonia in the ICU with results from a COMBACTE-NET #clinicaltrial . Don't miss it! Innovative Health Initiative EFPIA Laboratory of Medical Microbiology UA #ECCMID2024 #ESCMIDGlobal2024 ESCMID Juan Pablo Rodríguez

Proud & excited to once again partake in #ECCMID2024 #ESCMIDGlobal2024 at the Ecraid booth E81! Stop by for more information on Ecraid & what it can offer as an international #research foundation Innovative Health Initiative ESCMID EFPIA EUScience&Innovation🇪🇺 European Commission UMC Utrecht

Join us online on 31 May 2024 for our Impact event on #AMR ! Discover how the COMBACTE projects leveraged #PPP to combat #AntimicrobialResistance , which causes more than 35K deaths/year.
🗓️31 May
⏰ 14:00-15:30 CET
👉Register: europa.eu/!V6mTBY
#EUResearch #EUInnovation

🚨Major milestone for the treatment of patients with multidrug-resistant infections!

Discover how 🇪🇺co-funded project COMBACTE supported the development of an antibiotic that will offer new hope to those suffering with infections due to antibiotic-resistant bacteria exposure 👇

A really strong theme running through COMBACTE-CARE was the solid #collaboration . There every step of the way, it paved the road leading to this major, crucial milestone.

@Pfizer press release: pfizer.com/news/press-rel…
Innovative Health Initiative press release: ihi.europa.eu/news-events/ne…

Ecraid

🎉 Today, a new IMI-supported treatment combatting serious infections caused by #AMR has been approved! 🏆 Congratulations to the COMBACTE -CARE project, which supported two of the EMBLAVEO clinical trials - REJUVENATE & REVISIT! More info: europa.eu/!tx8q8g #EUResearch

The EC adopted today the authorisation of a 🆕 innovative treatment that will help tackle antimicrobial-resistance!

👏 Congrats to COMBACTE for its important contribution to this major step forward in overcoming the escalating challenges of #AMR

🔗 europa.eu/!BRXxRH

REVERSE ABS Intervention just kicked off! Six hospitals in cohort 1 attended the implementation workshop in Zurich last week. It was an enriching event for both the hospitals and REVERSE. Together we can make a change! #AMR
Lauren Clack Bianca Albers, PhD Pilar Retamar-Gentil Ash Sonpar

Calling all young researchers passionate about #infectiousdiseases ! Join our highly-popular Young Investigator Workshop at #ECCMID2024 on 28 April. Learn about innovative #clinicalresearch models and our perpetual #observationstudies . Learn more here 👉ecraid.eu/news/young-inv…

See you at #ECCMID2024 ? Check out our science at the congress and pass by the Poster Area for more in-depth information!
Innovative Health Initiative ESCMID Ecraid Infection & Immunity UMC Utrecht Marc Bonten

Last month the ECRAID-Base lab team held a webinar to present a sample collection and management manual for urinary tract infections 🧫🔬

▶️ A recording is now available.

Watch it 👉🏾 channel.ersnet.org/hp-26-1-eu-pro…